AKAP12IGFBP4

Yuye Shi1, Xiaohu Xu1, Zhengmei He1

  • 1Department of Hematology, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, China.

Acta haematologica
|August 22, 2023
PubMed
概括

这项研究确定AKAP12和IGFBP4是慢性淋巴细胞白血病 (CLL) 的关键预后因素. 这些基因提高了预测患者存活率和了解疾病进展的准确性.